FIORY, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.040
EU - Europa 451
AS - Asia 317
AF - Africa 12
Totale 1.820
Nazione #
US - Stati Uniti d'America 1.002
IT - Italia 179
SG - Singapore 168
CN - Cina 137
NL - Olanda 58
IE - Irlanda 57
FI - Finlandia 45
CA - Canada 38
SE - Svezia 38
DE - Germania 28
UA - Ucraina 18
GB - Regno Unito 16
CI - Costa d'Avorio 12
PL - Polonia 6
IN - India 5
FR - Francia 4
JP - Giappone 3
TR - Turchia 3
ES - Italia 1
KR - Corea 1
SI - Slovenia 1
Totale 1.820
Città #
Chandler 213
Singapore 143
Ashburn 97
Santa Clara 68
Napoli 67
Amsterdam 56
Millbury 52
Princeton 48
Nanjing 38
Ottawa 36
Boston 33
Jacksonville 29
Beijing 26
Des Moines 21
Wilmington 13
Washington 11
Shenyang 9
Hebei 8
Jiaxing 8
Naples 8
Tianjin 8
Lawrence 7
Norwalk 7
Nanchang 6
Boardman 5
Kunming 5
Cava De' Tirreni 4
Falls Church 4
Hangzhou 4
Pune 4
Caserta 3
Dallas 3
Hanover 3
Jinan 3
Los Angeles 3
Paris 3
Seattle 3
Casoria 2
Centrale 2
Citta Sant'angelo 2
Dalmine 2
Guangzhou 2
Houston 2
Kronberg 2
Maddaloni 2
Milan 2
Ningbo 2
Osaka 2
Scafati 2
Skövde 2
Zhengzhou 2
Altavilla Silentina 1
Ann Arbor 1
Atella 1
Augusta 1
Aversa 1
Bacoli 1
Carrara 1
Changchun 1
Changsha 1
Clifton 1
Council Bluffs 1
Dublin 1
Fairfield 1
Falkenstein 1
Fossombrone 1
Frankfurt am Main 1
Giugliano in Campania 1
Helsinki 1
Kagoya 1
Lappeenranta 1
Mainz 1
Melito Di Napoli 1
Munich 1
New York 1
Nocera Inferiore 1
Pesaro 1
Pompei 1
Roseto degli Abruzzi 1
San Cipriano Picentino 1
Sant'antonio Abate 1
Saskatoon 1
Secaucus 1
Shanghai 1
Shaoxing 1
Shenzhen 1
Stockholm 1
Sutton 1
Swindon 1
Taizhou 1
Tappahannock 1
The Dalles 1
Toronto 1
Turin 1
Villar Perosa 1
Vimercate 1
Xiamen 1
Totale 1.133
Nome #
Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes 70
Prep1 Deficiency Affects Olfactory Perception and Feeding Behavior by Impairing BDNF-TrkB Mediated Neurotrophic Signaling 69
Potential Mechanisms of Bisphenol A (BPA) Contributing to Human Disease 64
Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol-kinase subcellular localization. 61
Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteasomal degradation. 59
Altered PTPRD DNA methylation associates with restricted adipogenesis in healthy first-degree relatives of Type 2 diabetes subjects 56
Adenoviral gene transfer of PLD1-D4 enhances insulin sensitivity in mice by disrupting phospholipase D1 interaction with PED/PEA-15. 53
Insulin receptor substrate-2 phosphorylation is necessary for protein kinase czeta activation by insulin in l6hir cells. 49
Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity 48
Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice 47
miR-214-dependent increase of PHLPP2 levels mediates the impairment of insulin-stimulated akt activation in mouse aortic endothelial cells exposed to methylglyoxal 47
Citrus aurantium L. dry extracts promote C/ebpβ expression and improve adipocyte differentiation in 3T3-L1 cells. 47
Specific CpG hyper-methylation leads to Ankrd26 gene down-regulation in white adipose tissue of a mouse model of diet-induced obesity 46
Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II. 44
The Relevance of Insulin Action in the Dopaminergic System 43
Pathologic endoplasmic reticulum stress induced by glucotoxic insults inhibits adipocyte differentiation and induces an inflammatory phenotype 42
A peptide antagonist of Prep1-p160 interaction improves ceramide-induced insulin resistance in skeletal muscle cells 42
Alterations of PED/PEA-15 gene at the interface of diabetes and Parkinson disease 41
In L6 cells, glucose induces cytosolic translocation of PKC alpha, trans-activates the insulin receptor kinase and regulates its own uptake 41
The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells 41
Methylglyoxal impairs insulin signalling and endothelial function both in vitro and in vivo 39
In skeletal muscle, advanced glycation end products inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs. 38
Role of the HIF-1α/Nur77 axis in the regulation of the tyrosine hydroxylase expression by insulin in PC12 cells 38
Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells 37
Insulin affects tyrosine hydroxylase expression in neuronal PC12 cells through Hif-1alpha activation 37
Unravelling the methylglyoxal effect on the angiogenic process 37
Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. 35
Insulin induces the interaction of IRS-1 with PKC-alpha and 14-3-3-epsilon 35
Selective disruption of insulin-like growth factor-1 (IGF-1) signaling via phosphoinositide-dependent kinase-1 prevents the protective effect of IGF-1 on human cancer cell death. 34
Thrombin-activated platelets induce proliferation of human skin fibroblasts by stimulating autocrine production of insulin-like growth factor-1 33
Insulin receptor internalization and intracellular sorting are regulated by protein kinase C-zeta and protein kinase b/Akt. 33
Insulin regulates tyrosine hydroxylase expression in neuronal pc12 cells 33
GRP78 mediates cell growth and invasiveness in endometrial cancer. 32
Dicarbonyl Stress at the Crossroads of Healthy and Unhealthy Aging 31
Diabetes and cognitive impairment: A role for glucotoxicity and dopaminergic dysfunction 31
In L6 skeletal muscle tells advanced glycation end products inhibit insulin action by activating src and inducing the formation of a multi-molecular complex 30
Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo. 30
The role of miR-190a in methylglyoxal-induced insulin resistance in endothelial cells 30
Targetting PED/PEA-15 for diabetes treatment 29
Hyperglycaemia enhances the expression of the diabetogene ped/pea-15 through chromatin remodelling 28
The Role of miRNAs in Methylglyoxal-induced Endothelial Insulin Resistance 27
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase 25
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts. 25
PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1 25
Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling 24
Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea-15 24
Protein kinase C-alpha regulates insulin action and degradation by interacting with insulin receptor substrate-1 and 14-3-3 epsilon. 22
PDK1 interaction with insulin receptor and tyrosine phosphorylation are required for insulin metabolic action. 22
Metformin dysregulates the unfolded protein response and the WNT/β-catenin pathway in endometrial cancer cells through an AMPK-independent mechanism 22
Protein kinase C-zeta and protein kinase B regulate distinct steps of insulin endocytosis and intracellular sorting 21
The serine protease OMI/HtrA2 interacts with PED (phosphoprotein enriched in diabetes) and controls its anti-apoptotic function 21
Thiazolidinediones control the expression of Ped/Pea-15 (phosphoprotein enriched in diabetes) both in vitro and in vivo 21
Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action 20
Insulin stimulates phosphoinositides-dependent kinase (PDK)-1 binding to insulin-receptor C-terminus followed by tyrosine-phosphorylation and activation. 20
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer 17
Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. 14
Totale 2.030
Categoria #
all - tutte 9.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.369


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 0 0 0 6 1 1 1 9 9 32 29
2020/2021163 11 4 30 6 6 27 45 4 18 5 6 1
2021/2022357 5 1 0 2 11 10 3 8 63 16 105 133
2022/2023449 58 54 26 17 55 63 0 30 64 57 17 8
2023/2024283 10 42 19 40 27 57 2 22 2 4 41 17
2024/2025263 72 75 3 13 100 0 0 0 0 0 0 0
Totale 2.030